Literature DB >> 8970680

Acquisition of host cell-surface-derived molecules by HIV-1.

I Frank1, H Stoiber, S Godar, H Stockinger, F Steindl, H W Katinger, M P Dierich.   

Abstract

OBJECTIVE: To determine the acquisition of host cell-membrane-derived molecules by HIV-1 during the budding process, and to investigate whether the uptake of these molecules is cell-type-specific and selective.
DESIGN: Virions, propagated by four different cell types were analysed for the presence of adhesion molecules, glycosylphosphatidylinositol (GPI)-anchored proteins and various cell-surface markers. The pattern was compared with the phenotype of the HIV-1-infected cell.
METHODS: For phenotypic analysis of virions a two-step assay was used. In the first step, virus was captured with monoclonal antibodies (in some cases polyclonal sera) against different cell-membrane proteins. In a second step, the presence of virus was measured by determining the concentration of the virus-specific p24 core antigen. The expression of surface molecules on uninfected and HIV-1IIIB-infected cells was analysed by FACS.
RESULTS: Depending on the cell type used for virus propagation, different cell-membrane molecules were found on the virus surface reflecting the corresponding cell type. The uptake of these molecules was selective to a certain degree. No CD4 and CD87 molecules were detectable on HIV-1, although both molecules were present on uninfected and HIV-1-infected cells. CR3 and CDw108 could not be seen on uninfected cells, but wre detectable on infected cells and virions.
CONCLUSIONS: During the budding process HIV-1 acquires a variety of cell-type-specific cell-surface molecules. Certain cell-membrane molecules become upregulated during HIV-1-infection and are then found on virions, whereas other molecules remain on the cell surface and do not become incorporated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970680     DOI: 10.1097/00002030-199612000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  43 in total

1.  Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.

Authors:  L Kacani; W M Prodinger; G M Sprinzl; M G Schwendinger; M Spruth; H Stoiber; S Döpper; S Steinhuber; F Steindl; M P Dierich
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection.

Authors:  S D Lawn; B D Roberts; G E Griffin; T M Folks; S T Butera
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Haptoglobin polymorphism in a HIV-1 seropositive Brazilian population.

Authors:  T R Zaccariotto; E T Rosim; D Melo; P M D Garcia; R R Munhoz; F H Aoki; M de Fatima Sonati
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

Review 4.  Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.

Authors:  S Phogat; R T Wyatt; G B Karlsson Hedestam
Journal:  J Intern Med       Date:  2007-07       Impact factor: 8.989

5.  HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.

Authors:  Gaia Vasiliver-Shamis; Michael L Dustin; Catarina E Hioe
Journal:  Viruses       Date:  2010-05-01       Impact factor: 5.048

6.  Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.

Authors:  Yannick Beauséjour; Michel J Tremblay
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.

Authors:  Jean-François Giguère; Michel J Tremblay
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Heterosexual and homosexual partners practising unprotected sex may develop allogeneic immunity and to a lesser extent tolerance.

Authors:  Cherry Kingsley; Barry Peters; Kaboutar Babaahmady; Laura Pomeroy; Durdana Rahman; Robert Vaughan; Thomas Lehner
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

9.  Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors.

Authors:  Barbara Falkensammer; Barbara Rubner; Alexander Hiltgartner; Doris Wilflingseder; Christiane Stahl Hennig; Seraphin Kuate; Klaus Uberla; Stephen Norley; Alexander Strasak; Paul Racz; Heribert Stoiber
Journal:  Retrovirology       Date:  2009-06-21       Impact factor: 4.602

Review 10.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.